Paroxysmal Cold Hemoglobinuria Workup
- Author: Neetu Radhakrishnan, MD; Chief Editor: Emmanuel C Besa, MD more...
The diagnosis of autoimmune hemolytic anemia (AIHA) is usually straightforward and made on the basis of the following laboratory findings:
Normocytic or macrocytic anemia
Low serum haptoglobin levels
Elevated lactate dehydrogenase (LDH) level
Increased indirect bilirubin level
A positive direct antiglobulin test with a broad-spectrum antibody against immunoglobulin and complement
Two pieces of information are of utmost importance for the clinician to make an appropriate treatment decision: (1) What type of the antibody is involved? (2) Is the AIHA primary or secondary?
The type of antibody can be identified with the use of monospecific antibodies to immunoglobulin G (IgG) and C3d. When the red cells are coated with IgG or IgG plus C3d, the antibody is usually a warm antibody (warm antibody AIHA [WAIHA]). When the red cells are coated with C3d only, the antibody is often but not always a cold antibody. In some cases (direct antiglobulin test negativity, IgM warm antibodies, cold antibodies with low titers, or Donath-Landsteiner antibodies), diagnosis may be difficult, and the expertise of an immune-hematologic laboratory is required.
For the diagnosis of secondary AIHA, a careful history, including information on the onset (acute or insidious), history of infections, information on recent transfusions, exposure to drugs or vaccination, signs of immune disease (arthritis), and general clinical condition, is helpful. The exclusion of a drug-induced hemolytic anemia is particularly important, because stopping the drug is the most effective therapeutic measure in this situation. A clinical examination (to rule out lymphadenopathy and splenomegaly) is needed.
Blood cell studies
Findings on complete blood cell (CBC) count, differential, reticulocyte count, absolute reticulocyte count, platelet count, and peripheral blood smear are as follows:
A sudden onset of a marked normochromic, normocytic, or macrocytic anemia may be noted in paroxysmal cold hemoglobinuria, particularly in a severe attack.
The reticulocyte count is usually low during an acute episode, representing an ineffective marrow response either to viral hematopoietic suppression or preferential destruction of RBCs by the D-L antibody. Reticulocytosis occurs with resolution of the antibody.
Examination of the peripheral blood smear may briefly reveal the presence of poikilocytosis, spherocytes, polychromasia, and nucleated RBCs. Aggregation of the RBCs can occur, but this is considered mild compared with cold hemagglutinin disease. 
Monocytes and granulocytes may show erythrophagocytosis. Although more commonly seen in other types of autoimmune hemolytic anemia, the specific presence of RBC engulfment by neutrophils within the peripheral blood has a stronger association with paroxysmal cold hemoglobinuria and should make the observer suspicious for this entity. [34, 36, 37]
In the early part of an acute attack, the urine is dark red-brown because of the presence of free hemoglobin or methemoglobin. Hematuria is generally absent in paroxysmal cold hemoglobinuria, although a minimal quantity of RBCs can be seen (reported as large blood but only few RBCs).
Hemosiderin associated with a chronic hemolytic process is detectable. Kidney tubular epithelial cells, containing a deposition of hemosiderin, are shed and collected in urine.
Serum chemistry and complement studies
Test results for acute hemolysis are usually positive and include the following:
Elevated LDH level
Increased indirect or unconjugated bilirubin levels (particularly prominent if concomitant liver dysfunction is present)
Low haptoglobin values
The presence of free plasma hemoglobin
Due to consumption during the acute phase of massive hemolysis, measured plasma complement levels, such as C2, C3, and C4, are decreased in paroxysmal cold hemoglobinuria.
Infectious disease testing
Evaluation for suspected underlying infectious diseases, if clinically warranted, may include the following:
Test plasma for Treponema pallidum antibody
Obtain serologic evaluation for the following viruses: measles, mumps, influenza, varicella-zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), adenovirus, parvovirus B19, Coxsackie A9
Perform Gram smear and culture for bacteria such as Haemophilus influenzae, Mycoplasma pneumoniae, and Klebsiella
Review thick and thin smears for malaria
Direct antiglobulin testing
The direct antiglobulin test (direct Coombs test, DAT) should be performed with monoclonal anti-IgG, polyclonal screening antisera and monoclonal C3 antisera. Polyclonal screening antisera are inadequate for this purpose because they have poor sensitivity to complement components.
Monoclonal C3 antisera generally show DAT positivity due to C3d fragments on the RBCs. This reaction occurs during or shortly after the acute paroxysmal cold hemoglobinuria hemolytic episode.
Monoclonal anti-IgG DAT results are usually negative. This is thought to be due to the restrictive thermal range of the D-L antibody, which dissociates at the warmer temperatures at which the DAT is generally performed.[39, 40, 41, 42] Alternatively, if the blood is tested at cold temperatures, then the DAT result may also be positive.
The Donath-Landsteiner test
The procedure involves incubating three specimens: (1) the patient's serum, (2) a mix of patient's and normal serum, and (3) normal serum with P-positive RBCs at 4° C. The sample is heated to 37° C, followed by visual analysis of the serum for hemolysis, which is indicative of a positive reaction (see image below). If the D-L antibody is present, samples 1 and 2 should be positive. As negative controls, the three samples are replicated at testing conditions in which temperature is maintained at 4°C and 37°C throughout.
Because complement may be readily consumed during sample processing, leading to a false-negative result, normal ABO-compatible serum is provided as an additional complement source.
Test considerations are as follows:
The serum reacts equally well with normal adult RBCs and fetal RBCs; only the rare pp RBCs (homozygous for the absence of P antigen) do not react 
Modification of the Donath-Landsteiner test is done to enhance the antigenicity of the RBCs; this is performed by exposing the erythrocytes to an enzyme, papain, treatment, which then further unveils group P antigens 
The specificity of the antibody-mediated hemagglutination and antibody-complement–mediated hemolysis can be confirmed further by inhibition of these processes by globoside and Forssman glycosphingolipid 
Indirect antiglobulin test
Another interesting technique is to demonstrate the D-L antibody with a modified indirect Coombs test. Control (normal) RBCs are incubated with the patient's serum that contains the D-L antibody. These RBCs are washed with ice-cold saline solution to avoid dissociating the D-L antibody from the RBCs. Monoclonal IgG antiserum is then added.
This test is a sensitive indicator of the presence of the D-L antibody in the patient's serum. Note that the antibody in cold agglutinin disease is usually an IgM.
The D-L antibody test, DAT, and the indirect antiglobulin test are all useful in confirming the clinical diagnosis of paroxysmal cold hemoglobinuria.
If the Donath-Landsteiner test results are negative or equivocal and a cold reacting antibody is still suspected, perform a cold agglutinin titer. For definite diagnosis of a cold antibody AIHA (CAIHA), the cold agglutinin titer should be markedly elevated (> 1:512). Titers greater than 64 are likely due to a CHD antibody, although hemolysis rarely occurs at titers less than 1000.
Test for the presence of CD55 or CD59 on the RBC membrane if paroxysmal nocturnal hemoglobinuria is suspected (see Differentials). Flow cytometry is a more sensitive tool to help exclude the presence of paroxysmal nocturnal hemoglobinuria when compared with the classic standard Ham test or sugar water test.
Although results from imaging studies do not define the diagnosis of paroxysmal cold hemoglobinuria, the findings can assist in identifying an underlying contributory condition. Appropriate imaging studies include a chest radiograph to look for pneumonia or CT scans to look for lymphoproliferative disease in suspected appropriate cases.
Because hemosiderin is a known nephrotoxic agent, patients undergoing severe hemolysis should avoid further exposure to renal irritants such as intravenous pyelogram dye.
The presence of lymphadenopathy is suggestive of infection, lymphoma, or other underlying disease. Excisional biopsy of enlarged lymph nodes, with flow cytometry and gene rearrangement studies, may prove useful in such cases.
The need for additional investigations must be determined by history, clinical findings, and the type of antibody. Routine workup relevant for treatment decisions may include abdominal examination by CT scan (eg, to search for splenomegaly, abdominal lymphomas) or a bone marrow examination and a search for clonal immunoglobulins (immune fixation), serum protein electrophoresis, and quantitative determination of immunoglobulins in case of cold antibodies.
Donath J, Landsteiner K. Uber paroxysmale haemoglobinurie. Munchen Medicine Wochenschr. 1904. 51:1590-3.
Gottsche B, Salama A, Mueller-Eckhardt C. Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang. 1990. 58(4):281-6. [Medline].
Eder AF. Review: acute Donath-Landsteiner hemolytic anemia. Immunohematology. 2005. 21(2):56-62. [Medline].
Kypson AP, Warner JJ, Telen MJ, Milano CA. Paroxysmal cold hemoglobinuria and cardiopulmonary bypass. Ann Thorac Surg. 2003 Feb. 75(2):579-81. [Medline].
Taylor CJ, Neilson JR, Chandra D, Ibrahim Z. Recurrent paroxysmal cold haemoglobinuria in a 3-year-old child: a case report. Transfus Med. 2003 Oct. 13(5):319-21. [Medline].
Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis associated with Donath-Landsteiner antibodies. Acta Haematol. 1982. 68(4):268-77. [Medline].
Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984. 72(4):245-57. [Medline].
Win N, Stamps R, Knight R. Paroxysmal cold haemoglobinuria/Donath-Landsteiner test. Transfus Med. 2005 Jun. 15(3):254. [Medline].
Vaglio S, Arista MC, Perrone MP, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion. 2007 Jan. 47(1):50-4. [Medline].
Breccia M, D'Elia GM, Girelli G, et al. Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosis. Eur J Haematol. 2004 Oct. 73(4):304-6. [Medline].
Wynn RF, Stevens RF, Bolton-Maggs PH, Schwe K, Will AM. Paroxysmal cold haemoglobinuria of childhood: a review of the management and unusual presenting features of six cases. Clin Lab Haematol. 1998 Dec. 20(6):373-5. [Medline].
Bell CA, Zwicker H, Rosenbaum DL. Paroxysmal cold hemoglobinuria (P.C.H.) following mycoplasma infection: anti-I specificity of the biphasic hemolysin. Transfusion. 1973 May-Jun. 13(3):138-41. [Medline].
Rausen AR, LeVine R, Hsu TC, Rosenfield RE. Compatible transfusion therapy for paroxysmal cold hemoglobinuria. Pediatrics. 1975 Feb. 55(2):275-8. [Medline].
Petz LD, Garratty G. Acquired Immune Hemolytic Anemias. New York, NY: Churchill Livingstone; 1980. 37-50.
Dacie J. The Haemolytic Anaemias. 3rd ed. New York, NY: Churchill Livingstone; 1992. 210-362.
Ziman A, Hsi R, Goldfinger D. Transfusion Medicine Illustrated: Donath-Landsteiner antibody-associated hemolytic anemia after Haemophilus influenzae infection in a child. Transfusion. 2004 Aug. 44(8):1127-8. [Medline].
Vergara LH, Mota MC, Sarmento Ada G, Duarte CA, Barbot JM. [Acute renal failure secondary to paroxysmal cold hemoglobinuria] [Spanish]. An Pediatr (Barc). 2006 Mar. 64(3):267-9. [Medline]. [Full Text].
Kim GM, Kim CH, Kim BS. Multiple cerebral infarction and microbleeds associated with adult-onset paroxysmal cold hemoglobinuria. J Clin Neurosci. 2009 Feb. 16(2):348-9. [Medline].
Papalia MA, Schwarer AP. Paroxysmal cold haemoglobinuria in an adult with chicken pox. Br J Haematol. 2000 May. 109(2):328-9. [Medline].
Lippman SM, Winn L, Grumet FC, Levitt LJ. Evans' syndrome as a presenting manifestation of atypical paroxysmal cold hemoglobinuria. Am J Med. 1987 May. 82(5):1065-72. [Medline].
Sharara AI, Hillsley RE, Wax TD, Rosse WF. Paroxysmal cold hemoglobinuria associated with non-Hodgkin's lymphoma. South Med J. 1994 Mar. 87(3):397-9. [Medline].
Sivakumaran M, Murphy PT, Booker DJ, et al. Paroxysmal cold haemoglobinuria caused by non-Hodgkin's lymphoma. Br J Haematol. 1999 Apr. 105(1):278-9. [Medline].
Stefanizzi C, Breccia M, Santopietro M, et al. Unusual association of paroxysmal cold hemoglobinuria as the first sign of disease in myelodysplastic patient. Int J Hematol. 2009 Jun. 89(5):720-1. [Medline].
Sinha A, Richardson G, Patel RT. Cold agglutinin related acrocyanosis and paroxysmal haemolysis. Eur J Vasc Endovasc Surg. 2005 Nov. 30(5):563-5. [Medline].
Chrobak L. Paroxysmal nocturnal hemoglobinuria (membrane defect, pathogenesis, aplastic anemia, diagnosis). Acta Medica (Hradec Kralove). 2000. 43(1):3-8. [Medline].
Prasad AS, Berman L, Tranchida L, Poulok MD. Red cell hypoplasia, cold hemoglobinuria and M-type gamma G serum paraprotein and Bence Jones proteinuria in a patient with lymphoproliferative disorder. Blood. 1968 Feb. 31(2):151-65. [Medline]. [Full Text].
Subbarayan PR, Shichishima T, Yoshida H, Maruyama Y, Naiki M. Report on a patient with paroxysmal cold hemoglobinuria. Int J Hematol. 1997 Feb. 65(2):165-7. [Medline].
Chen R, Nagarajan S, Prince GM, et al. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2000 Sep. 106(5):689-96. [Medline]. [Full Text].
Brodsky RA, Mukhina GL, Li S, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000 Sep. 114(3):459-66. [Medline].
Garratty G. Erythrophagocytosis on the peripheral blood smear and paroxysmal cold hemoglobinuria. Transfusion. 2001 Aug. 41(8):1073-4. [Medline].
Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010 Sep 16. 116(11):1831-8. [Medline].
Roy-Burman A, Glader BE. Resolution of severe Donath-Landsteiner autoimmune hemolytic anemia temporally associated with institution of plasmapheresis. Crit Care Med. 2002 Apr. 30(4):931-4. [Medline].
Nordhagen R, Stensvold K, Winsnes A, Skyberg D, Storen A. Paroxysmal cold haemoglobinuria. The most frequent acute autoimmune haemolytic anaemia in children?. Acta Paediatr Scand. 1984 Mar. 73(2):258-62. [Medline].
Lindgren S, Zimmerman S, Gibbs F, Garratty G. An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transfusion. 1985 Mar-Apr. 25(2):142-4. [Medline].
Nordhagen R. Two cases of paroxysmal cold hemoglobinuria with a Donath-Landsteiner antibody reactive by the indirect antiglobulin test using anti-IgG. Transfusion. 1991 Feb. 31(2):190-1. [Medline].
Thomas AT. Autoimmune hemolytic anemias. Lee GR, Foerster J, Lukens J, et al, eds. Wintrobe's Clinical Hematology. 10th ed. Baltimore, Md: Williams & Wilkins; 1999. 1233-63.
Gertz MA. Management of cold haemolytic syndrome. Br J Haematol. 2007 Aug. 138(4):422-9. [Medline].
Hothi DK, Bass P, Morgan M, et al. Acute renal failure in a patient with paroxysmal cold hemoglobinuria. Pediatr Nephrol. 2007 Apr. 22(4):593-6. [Medline].
Koppel A, Lim S, Osby M, Garratty G, Goldfinger D. Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria. Transfusion. 2007 Oct. 47(10):1902-4. [Medline].
Gregory GP, Opat S, Quach H, Shortt J, Tran H. Failure of eculizumab to correct paroxysmal cold hemoglobinuria. Ann Hematol. 2011 Aug. 90(8):989-90. [Medline].